Clinical Trial Update: A Study to Compare the Effect of Transipeg 2.95 g or Forlax Junior 4 g in Children With Constipation [Phase 4]

View source ↗

Summary

Phase 4 trial update comparing Transipeg 2.95 g and Forlax Junior 4 g for constipation in children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation

Drugs mentioned

• Forlax Junior 4 g (polyethylene glycol 3350)
• Transipeg 2.95 g (polyethylene glycol 3350)

Snippet

Sponsor: Bayer | Conditions: Constipation | Phase 4 | Status: COMPLETED